{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/26569632"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "BioTime, Inc. (NYSE MKT: BTX) and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a definitive Asset Contribution Agreement with Geron Corporation (Nasdaq: GERN) to acquire the intellectual property, including patents and patent applications, and other assets related to Geron???s human embryonic stem (hES) cell programs consi" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "pharmiweb.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/462533485"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/26569632" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/103672564"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/26569632"] } } }
